This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Dividend Growth Stocks to Buy on Trump Win & Fed Rate Cut
by Sweta Killa
Trump's re-election and the Fed rate cut bring back the lure for dividend investing. We have highlighted five solid picks that promise growth.
Leidos Holdings, Inc. (LDOS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Leidos (LDOS). This makes it worthwhile to examine what the stock has in store.
Zacks.com featured highlights include Alphabet, Leidos and Regions Financial
by Zacks Equity Research
Alphabet, Leidos and Regions Financial are part of the Zacks Screen of the Week article.
Is Leidos (LDOS) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Leidos (LDOS) possesses solid growth attributes, which could help it handily outperform the market.
Leidos (LDOS) Is Up 8.45% in One Week: What You Should Know
by Zacks Equity Research
Does Leidos (LDOS) have what it takes to be a top stock pick for momentum investors? Let's find out.
LDOS or EADSY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LDOS vs. EADSY: Which Stock Is the Better Value Option?
Buy 3 High ROE Stocks as Markets Surge on Trump's Election Win
by Supriyo Bose
GOOGL, LDOS and RF are some of the stocks with high ROE to profit from as markets hit record-high tallies on Trump's victory.
RTX's Jet Engine to Operate With 100% SAF: Should You Buy the Stock?
by Aparajita Dutta
Investors interested in RTX should wait for a better entry point. However, those who already own it might continue to do so.
This Top Aerospace Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Zacks.com featured highlights include IAMGOLD, Leidos, Brinker International, Phibro Animal Health and State Street
by Zacks Equity Research
AMGOLD, Leidos, Brinker International, Phibro Animal Health and State Street are part of the Zacks Screen of the Week article.
Zacks.com featured highlights include Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International
by Zacks Equity Research
Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International are part of the Zacks Screen of the Week article.
5 PEG-Based GARP Stocks to Buy Amid Election Week Volatility
by Urmimala Biswas
Here are five stocks with a discounted PEG ratio, BABA, PFE, VIRT, LDOS and EAT, suitable for GARP investors.
Leidos Holdings, Inc. (LDOS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Leidos (LDOS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Stocks Trading Near 52-Week High With More Upside Potential
by Vasundhara Sawalka
Stocks like IAG, LDOS, EAT, PAHC and STT are seeing price strength and have a high chance of carrying the momentum forward.
Leidos Holdings and Leggett & Platt have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Leidos Holdings and Leggett & Platt are part of the Zacks Bull and Bear of the Day article.
Zacks.com featured highlights include Leidos Holdings, Peloton Interactive, ZIM Integrated Shipping Services, Brinker International and Enova International
by Zacks Equity Research
Leidos Holdings, Peloton Interactive, ZIM Integrated Shipping Services, Brinker International and Enova International are part of the Zacks Screen of the Week article.
If You Invested $1000 in Leidos a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Bull of the Day: Leidos Holdings (LDOS)
by Bryan Hayes
Increased contract wins from the Pentagon and other US allies have been a primary growth driver for the company.
Surging Earnings Estimates Signal Upside for Leidos (LDOS) Stock
by Zacks Equity Research
Leidos (LDOS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stock to Buy for November 1st
by Zacks Equity Research
SFM, FSFG and LDOS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 1, 2024.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Brokers Suggest Investing in Leidos (LDOS): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Leidos (LDOS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Now is the Time to Accumulate 5 Relative Price Strength Stocks
by Nilanjan Choudhury
LDOS, PTON, ZIM, EAT and ENVA are five stocks with explosive relative price strength.
Play Likely Earnings Beat With 4 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Leidos (LDOS) and American Airlines (AAL) are likely to beat on the bottom line in their upcoming releases.
New Strong Buy Stocks for November 1st
by Zacks Equity Research
SKY, AAT, SOHO, THC and LDOS have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2024.